Public endorsements by well-known investors often lead to short-term increases in stock prices due to heightened investor interest and perceived validation of the company's prospects. Josh Brown's announcement of doubling down on Pfizer on a high-profile platform like CNBC is likely to attract attention to Pfizer's stock, potentially driving up its price in the short term.